==== Front
J Gynecol OncolJ Gynecol OncolJGOJournal of Gynecologic Oncology2005-03802005-0399Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 10.3802/jgo.2018.29.e80ErratumErratum: Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube https://orcid.org/0000-0003-4509-6731Choi Min Chul 12https://orcid.org/0000-0002-6897-8115Bae Jin-Sik 3https://orcid.org/0000-0002-0635-6994Jung Sang Geun 2https://orcid.org/0000-0002-7825-9165Park Hyun 2https://orcid.org/0000-0003-4637-6946Joo Won Duk 2Song Seung Hun 2https://orcid.org/0000-0003-1654-4398Lee Chan 2https://orcid.org/0000-0001-6774-7553Kim Ji-Ho 3https://orcid.org/0000-0003-3582-9487Lee Ki-Chan 3https://orcid.org/0000-0002-6682-119XLee Sunghoon 3Lee Je Ho 121 Hereditary Gynecologic Cancer Clinic, Precision Medicine Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea.2 Department of Obstetrics and Gynecology, Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea.3 Eone-Diagnomics Genome Center (EDGC), Incheon, Korea.9 2018 20 6 2018 20 6 2018 29 5 e80Copyright © 2018. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology2018Asian Society of Gynecologic Oncology, Korean Society of Gynecologic OncologyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube
==== Body
The original article by Choi et al. entitled, “Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube” [1] contained errors.

Both the variant nomenclature of “p.Arg67fs” in CHAPC-003 and “p.Arg67Ilefs” are suitable according to Human Genome Variation Society (HGVS) recommendation. However, we have corrected “p.Arg67fs” to “p.Arg67Ilefs” in order to represent it in a more unified form with the other frame-shift variants.

The mutation and mutation type of case CHAPC-011 was corrected “c.2808_2011delACAA” to “c.2808_2811delACAA” and “p.Lys936fs” to “p.Ala938Profs.”

The variant description of "c.2164+16->A" in the cases CHAPC-008, CHAPC-009 and CHAPC-010 is the nomenclature of Annovar algorithm which was used to annotate mutations. It was changed to “c.2164+15_2164+16insA” according to the HGVS recommendation. This variation was described as variant of uncertain significance (VUS) in this article because it was unavailable in ClinVar at the time of publication. Meanwhile, in a recently published article by Caggiari et al. [2], the reference single nucleotide polymorphisms (SNPs) ID number of this variation was mentioned as “rs35686369” and it was described as benign in ClinVar.

The variant descriptions of “p.Leu630Val-” in the case CHATC-001 was corrected to “p.Leu630Val”.

In addition, we have also inserted hyphens in ‘Double primary,’ ‘Family history,’ and ‘FH of other cancer’ columns in the Table 2.

We attached the corrected Table 2 as shown below (modified values were underlined, except error 5).

Table 2. Detected germline mutations and VUS of BRCA1/2, TP53, PTEN, CDH1, PALB2 genes in PC/FTC patients



FH, family history; FTC, fallopian tube cancer; PC, primary peritoneal cancer; VUS, variants of unknown clinical significance.

*Breast cancer history of patient's own, †Family history of BRCA-related cancer within second degree relatives.
==== Refs
1 Choi MC  Bae JS  Jung SG  Park H  Joo WD  Song SH    Prevalence of germline BRCA  mutations among women with carcinoma of the peritoneum or fallopian tube J Gynecol Oncol 2018 29 e43 29770616 
2 Caggiari L  Miolo G  Buonadonna A  Basile D  Santeufemia DA  Cossu A    Characterizing metastatic HER2 -positive gastric cancer at the CDH1  haplotype Int J Mol Sci 2018 19 47